> What to know before RFK Jr.'s new vaccine advisers meet for first time
What to know before RFK Jr.'s new vaccine advisers meet for first time
Clip ID 2556917
Clearance
Add to
Share
Add to Review Link
By Request
By Request assets are not available for immediate purchase.
This content has not been pre-checked for copyright.
Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us
Description
U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers began their first meeting Wednesday under intense scrutiny from medical experts worried about Americans’ access to lifesaving shots.
First on the agenda is an awkward scenario: Kennedy already announced COVID-19 vaccines will no longer be recommended for healthy children or pregnant women, and his new advisers aren’t scheduled to vote on whether they agree. Yet government scientists prepared meeting materials calling vaccination “the best protection” during pregnancy — and said most children hospitalized for COVID-19 over the past year were unvaccinated.
COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months who could have some protection if their mom got vaccinated during pregnancy, according to the CDC's presentation.
It’s the first signal that this week’s two-day meeting of the Advisory Committee on Immunization Practices isn’t business as usual.
The panel, created more than 60 years ago, helps the CDC determine who should be vaccinated against a long list of diseases, and when. Those recommendations have a big impact on whether insurance covers vaccinations and where they’re available, such as at pharmacies.
Earlier this month, Kennedy abruptly dismissed the existing 17-member expert panel and handpicked the replacements, including several anti-vaccine voices. And a number of the CDC’s top vaccine scientists — including some who lead the reporting of data and the vetting of presentations at ACIP meetings — have resigned or been moved out of previous positions.